Molecular epidemiology competitors

Zippia score 4.0

Competitor Summary. See how Molecular epidemiology compares to its main competitors:

ABC Laboratories has the most employees (3,000).
The oldest company is ABC Laboratories, founded in 1968.

Work at Molecular epidemiology?

Share your experience

Molecular epidemiology vs competitors

Company	Founding date	Zippia score	Headquarters	# of Locations	Revenue	Employees
Molecular epidemiology	-	4.0	Lake Forest Park, WA	1	$14.0M	83
GENEWIZ	1999	4.1	South Plainfield, NJ	1	$45.4M	100
Source Molecular	2002	3.8	Miami, FL	2	$410,000	5
454 Life Sciences	2005	4.5	Branford, CT	1	$19.4M	100
Institute for Systems Biology	2000	4.3	Seattle, WA	1	$37.5M	230
Admera Health	2014	3.7	South Plainfield, NJ	1	$1.0M	75
Agdia	1981	3.9	Elkhart, IN	1	$11.0M	50
Invisible Sentinel	2006	4.2	Philadelphia, PA	1	$9.0M	39
Genetics Institute	1980	3.9	Cambridge, MA	1	$7.5M	500
Biocoat	1991	4.1	Horsham, PA	1	$10.9M	20
Lucigen	1998	4.4	Middleton, WI	4	$15.7M	20
Guardant Health	2012	3.6	Redwood City, CA	2	$739.0M	500
Integral Molecular	2001	3.8	Philadelphia, PA	1	$2.2M	12
ABC Laboratories	1968	4.2	Columbia, MD	1	$72.0M	3,000

Rate how well Molecular epidemiology differentiates itself from its competitors.

Molecular epidemiology salaries vs competitors

Compare Molecular epidemiology salaries vs competitors

Company	Average salary	Hourly salary	Salary score
Molecular epidemiology	$49,447	$23.77	-

Compare Molecular epidemiology job title salaries vs competitors

Company	Highest salary	Hourly salary
Molecular epidemiology	$33,657	$16.18
454 Life Sciences	$39,421	$18.95
GENEWIZ	$38,379	$18.45
Genetics Institute	$37,452	$18.01
ABC Laboratories	$37,367	$17.97
Institute for Systems Biology	$36,134	$17.37
Biocoat	$36,023	$17.32
Guardant Health	$34,546	$16.61
Lucigen	$34,064	$16.38
Admera Health	$33,869	$16.28
Agdia	$32,782	$15.76
Invisible Sentinel	$32,159	$15.46
Integral Molecular	$32,055	$15.41
Source Molecular	$32,044	$15.41

Do you work at Molecular epidemiology?

Does Molecular epidemiology effectively differentiate itself from competitors?

Molecular epidemiology jobs

Molecular epidemiology demographics vs competitors

Compare gender at Molecular epidemiology vs competitors

Job title	Male	Female
GENEWIZ	55%	45%
Institute for Systems Biology	56%	44%
454 Life Sciences	59%	41%
Agdia	70%	30%
Molecular epidemiology	-	-

Male

Female

100%

75%

50%

25%

Molecular epidemiology

Agdia

454 Life Sciences

Institute for Systems Biology

GENEWIZ

25%

50%

75%

100%

Compare race at Molecular epidemiology vs competitors

Company	White	Hispanic or Latino	Black or African American	Asian	Unknown	Diversity score
454 Life Sciences	58%	18%	8%	13%	2%	8.8
Agdia	62%	15%	7%	10%	6%	7.4
GENEWIZ	44%	12%	8%	32%	4%	8.2
Institute for Systems Biology	58%	11%	7%	19%	5%	9.0

Molecular epidemiology and similar companies CEOs

CEOBio

Cr Ocean Engineering

454 Life Sciences

CR Ocean Engineering is a Samuel W. Croll, III, Chief Executive Officer of CR Ocean Engineering at Life Sciences - Search Solution Group.

John D. Bucksath

ABC Laboratories

Jim Moran

Biocoat

Steve Sun

GENEWIZ

Ralph Kauten

Lucigen

Experienced Board Member and leader with a demonstrated history of working in the biotechnology industry. Skilled in Business Planning, Biotechnology, Team Leadership, Management, and Risk Financing. Strong business development professional with a MBA focused in Accounting from University of Wisconsin-Madison.

Nicholas Siciliano

Invisible Sentinel

Helmy Eltoukhy

Guardant Health

Helmy is a serial entrepreneur and pioneer in the biotech industry. After receiving his PhD, MS and BS degrees in electrical engineering from Stanford University, he joined the Stanford Genome Technology Center (SGTC) in 2006 to work on low-cost DNA sequencing technologies. At SGTC, he developed the first semiconductor sequencing platform and first base-calling algorithm for next-gen sequencing. In 2007, he co-founded Avantome to commercialize a low-cost, high-performance next-gen sequencing platform to seed the democratization of next-gen sequencing. As its founding CEO, he led Avantome through two rounds of financing and through acquisition by Illumina in 2008. At Illumina, Helmy was Sr Director of Advanced Technology Research, where he developed novel chemistries, hardware and informatics for genetic analysis systems.

Benjamin Doranz

Integral Molecular

Guanghui Hu

Admera Health